IRCT20211008052695N1招募中3 期
Evaluation of Atomoxetine efficacy on Freezing of gait in patient with Parkinson
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •1) Diagnosis of Parkinson's disease based on examination and history 2) Patients with stage 2-4 of Hoehn and yahr scale; 3) Normal tests (vitamin B12, thyroid, liver, and kidney tests) 4) Levodopa treatment for at least 3 months before the study 5) Ability to walk at least 20 steps without the use of assistive devices
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Study of therapeutic effects of Atomoxtein in reducing the symptoms of patients with recurrent vasovagal syncopeIRCT20180125038507N1Tehran University of Medical Sciences50
招募中
2 期
Study of the effect of Atomoxetine on cognitive symptoms in patients with schizophreniaIRCT20101130005280N31Mashhad University of Medical Sciences42
尚未招募
3 期
Atomoxetine for cognitive impairment in Behcet's diseaseBehcet's diseaseIRCT20211206053288N1Tehran University of Medical Sciences40
进行中（未招募）
1 期
Evaluation of the effect of Atomoxetine on impulsive state of High impulsive Tourette’s patients.EUCTR2019-004455-36-FRCHU DE POITIERS45
进行中（未招募）
不适用
An Open-Label Study of the Efficacy of Atomoxetine Hydrochloride on Quality of Life of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without comorbid conditions - NDChild or adolescent patients with Attention-Deficit/ Hyperactivity Disorder ADHDMedDRA version: 6.1Level: PTClassification code 10003736EUCTR2005-005701-32-ITELI LILLY300